Regulation of Src kinase activity during Xenopus oocyte maturation  by Tokmakov, Alexander et al.
www.elsevier.com/locate/ydbioDevelopmental BiologyRegulation of Src kinase activity during Xenopus oocyte maturation
Alexander Tokmakova,*, Tetsushi Iwasakib, Shuji Itakurac, Ken-Ichi Satob,c, Mikako Shirouzua,
Yasuo Fukamib,c, Shigeyuki Yokoyamaa,d
aGenomic Sciences Center, RIKEN Yokohama Institute, 1-7-22 Suehiro-cho, Tsurumi ku, Yokohama, Kanagawa 230-0045, Japan
bResearch Center for Environmental Genomics, Kobe University, Nada, Kobe 657-8501, Japan
cDepartment of Biology, Faculty of Science, Kobe University, Nada, Kobe 657-8501, Japan
dDepartment of Biophysics and Biochemistry, Graduate School of Science, The University of Tokyo, Tokyo 113-0033, Japan
Received for publication 28 June 2004, revised 26 October 2004, accepted 27 October 2004
Available online 21 November 2004Abstract
Expression of constitutively active Src protein tyrosine kinase in Xenopus oocytes has been shown to accelerate oocyte maturation
suggesting that Src may be involved in meiotic progression. However, meiotic regulation of endogenous Src kinase in oocytes has not been
investigated in detail. To address this problem, we measured the activity, expression level, and phosphorylation state of the endogenous
Xenopus Src (xSrc) and overexpressed xSrc mutants in the process of progesterone-induced oocyte maturation. We found that the enzyme is
first transiently activated in the plasma membrane-containing fraction of oocytes within 3 min of progesterone administration. This event
represents one of the earliest responses of oocytes to the hormone and should be related to triggering some early signaling pathways of
maturation. Thereafter, xSrc activity increases again at the time of germinal vesicle breakdown (GVBD) and remains elevated till the
completion of maturation. This elevation of xSrc activity is associated with a 2-fold increase of xSrc protein content in the absence of change
in its specific activity and xSrc mRNA content. No significant changes in the phosphorylation state of C-terminal regulatory phosphotyrosine
can be registered either in endogenous xSrc or in overexpressed kinase-negative and wild-type xSrc proteins during maturation. Altogether,
these results indicate that upregulation of xSrc in the meiotic metaphase occurs at the translation level. We also demonstrate here that the
expression of constitutively active xSrc in Xenopus oocytes is accompanied by the activation of mitogen-activated protein kinase (MAPK).
Our data suggest that the Src kinase acts through the MAPK pathway to accelerate oocyte maturation.
D 2004 Elsevier Inc. All rights reserved.
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Fully grown oocytes of the African clawed frog Xenopus
laevis are naturally arrested at the G2/prophase boundary of
the first meiotic division. They have intact nuclear envelope,
partially decondensed chromatin, abundant stock of mater-0012-1606/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2004.10.018
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down; IP3, inositol 1,4,5-trisphosphate; MAPK, mitogen-activated protein
kinase; MPF, maturation-promoting factor; PI3K, phosphatidylinositol 3-
kinase; PKA, cAMP-dependent protein kinase; PLC, phospholipase C; PR,
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E-mail address: tokmak@gsc.riken.go.jp (A. Tokmakov).nal mRNAs, and low activity of the key mitotic regulators,
maturation-promoting factor (MPF, a complex of cyclin B
and Cdc2 kinase) and cytostatic factor (CSF), defined
originally as a cytoplasmic activity from unfertilized eggs
that causes metaphase arrest upon transfer into dividing
embryos (Masui and Markert, 1971). Although a number of
proteins have been implicated as CSF components, its exact
molecular composition remains unknown. The Xenopus
mitogen-activated protein kinase (MAPK) cascade, includ-
ing Mos, MAPKK, MAPK, as well as MAPK downstream
kinase p90Rsk, has been shown to play an important role in
establishing CSF arrest in oocytes. Recently, the APCcdc20
inhibitor Emi1 has been identified as an essential compo-
nent required for maintaining the CSF-arrested state278 (2005) 289–300
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progesterone induces meiotic progression in Xenopus
oocytes converting them into fertilization-competent eggs
arrested at the metaphase of meiosis II. The finding that
progesterone can initiate oocyte maturation only when
applied externally, but not when injected into the cytoplasm
or the nucleus, together with the fact that MPF activation
can be induced in enucleated oocytes (Masui and Markert,
1971; Smith and Ecker, 1971) demonstrates unequivocally
that the steroid acts at the plasma membrane independently
of transcriptional changes. This action is different from
action of the classical nuclear steroid receptor and suggests
the existence of a nontranscriptional membrane-associated
signaling receptor. One of the earliest responses to
progesterone, a decrease in cAMP level due to partial
inhibition of plasma membrane adenylate cyclase (Finidori-
Lepicard et al., 1981; Schorderet-Slatkine et al., 1978),
implicates a G-protein-coupled transmembrane receptor.
The drop in cAMP concentration and subsequent decrease
in cAMP-dependent protein kinase (PKA) activity are
crucial for initiating maturation. Microinjection of PKA
inhibitors induces oocyte maturation in the absence of
progesterone, whereas injecting the PKA catalytic subunit
blocks progesterone-induced maturation (Huchon et al.,
1981; Maller and Krebs, 1977). Catalytically inactive PKA
was also found to block progesterone- or Mos-induced
oocyte maturation, suggesting a novel mechanism that may
be related to sequestration of proteins rather than phosphor-
ylating them (Schmitt and Nebreda, 2002). Another possible
candidate for nontranscriptional membrane progesterone
receptor is the classical nuclear progesterone receptor.
Recently, a Xenopus homolog of nuclear progesterone
receptor (xPR) has been cloned, whose overexpression
increased sensitivity to progesterone and accelerated germi-
nal vesicle breakdown (GVBD), Mos accumulation, and
MAPK activation (Bayaa et al., 2000; Tian et al., 2000).
Although initially this receptor could not be detected in the
oocyte membrane, where progesterone signaling is origi-
nated, more recent finding demonstrates that a minor
fraction of one form of the receptor (p82 xPR) is associated
with the plasma membrane-containing fraction (Bagowski et
al., 2001). Importantly, accelerated MAPK activation was
also registered upon receptor overexpression in enucleated
oocytes, implying that xPR can act through a nongenomic
mechanism. Still, a great difference in EC50 for transcrip-
tional activation by the classical progesterone receptor and
EC50 for GVBD suggests that a progesterone-binding
protein other than the classical receptor may be involved
in progesterone-induced oocyte maturation.
Both G-protein-coupled receptors and classical proges-
terone receptor were shown to activate the Src/Ras/MAPK
pathway. hg subunits of G proteins can recruit phosphati-
dylinositol 3-kinase (PI3K) g isoform to the membrane
(Stoyanov et al., 1995) where they create phosphatidylino-
sitol triphosphate docking sites for nonreceptor tyrosine
kinase Src (Dikic et al., 1996; Lopez-Ilasaca et al., 1997).Then, activated Src kinase promotes MAPK activation
through the assembly of a Ras-activating signaling complex.
PI3K activity is increased in progesterone-treated oocytes
and overexpression of constitutively active PI3Kg is able to
induce GVBD and stimulate MAPK (Hehl et al., 2001;
Muslin et al., 1993). Evidence is presented that Ras is an
essential component of oocyte maturation downstream of
PI3K (Hehl et al., 2001; Hu et al., 1995). On the other hand,
the classical progesterone receptor was found to contain a
proline-rich motif that interacts with and activates Src
family kinases (SFKs) by a SH3 domain displacement
mechanism (Boonyaratanakornkit et al., 2001). Thus, it was
also suggested to employ the Src/Ras/MAPK pathway
(Migliaccio et al., 1998). Although activation of a plasma
membrane-associated tyrosine kinase and low-level activa-
tion of MAPK have been registered in Xenopus oocytes
shortly after progesterone application (Fisher et al., 2000;
Morrison et al., 2000), neither the identity of progesterone-
activated tyrosine kinase is established nor a pathway
leading to MAPK activation is delineated.
In the present study, we investigated the activity and
regulation of Xenopus Src kinase (xSrc) during meiotic
maturation of Xenopus oocytes. A 57-kDa nonreceptor
protein tyrosine kinase xSrc is a major SFK expressed at the
protein level in Xenopus eggs (Sato et al., 1996); however,
some other SFKs, such as Fyn, Yes, Laloo, and so forth,
have been identified at the mRNA level (Steele et al., 1989a,
1990; Weinstein et al., 1998). Xenopus eggs were shown to
contain two highly homologous copies of the src gene,
presumably, due to the fact that the somatic genome of this
species is tetraploid (Steele, 1985). Thus, xSrc represents a
mixture of protein products encoded by src1 and src2 genes
(Steele et al., 1989b). Recently, it has been established to
play an important role in the processes of egg fertilization
and activation (Sato et al., 1999, 2000b). Although micro-
injection of activated Src kinase was shown to accelerate
progesterone-induced maturation of Xenopus oocytes (Spi-
vack et al., 1984), the regulation of endogenous xSrc during
oocyte maturation has not been investigated in detail.
Here, we demonstrate that the xSrc activity is transiently
elevated in the plasma membrane-containing fraction of
Xenopus oocytes within 3 min of progesterone treatment.
Specific activity of the enzyme is also increased at that
time, implying that xSrc activation takes place. xSrc
activity grows again later in meiosis at the time of MAPK
activation and GVBD. It is accompanied by a 2-fold
increase of Src protein content in the absence of change in
xSrc-specific activity. Overexpressing kinase-negative and
wild-type forms of xSrc in resting and maturing oocytes
demonstrated that, in contrast to mitotic Src regulation, no
significant changes in the phosphorylation state of C-
terminal regulatory tyrosine occur in meiosis. Also, the
content of xSrc mRNA remains constant during maturation.
These results indicate that upregulation of xSrc in meiotic
metaphase takes place at the level of protein expression.
We also demonstrate here that the expression of constitu-
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activation of MAPK in the absence of meiotic progression.
The timing of MAPK activation suggests that the Src
kinase acts through the MAPK pathway to accelerate
oocyte maturation.Experimental procedures
Materials
Female frogs of X. laevis were purchased from
Hamamatsu Seibutsu Kyozai (Hamamatsu, Japan). A
synthetic cdc2 peptide, corresponding to residues 7–26 of
the fission yeast cdc2 gene product, was synthesized as
described previously (Fukami et al., 1993). Anti-xSrc
polyclonal antibody was raised against a synthetic peptide
corresponding to residues 410–428 of chicken c-Src as
reported earlier (Sato et al., 1996). Polyclonal anti-MAPK
and anti-pMAPK antibodies were from Cell Signaling
(Beverly, MA), and anti-Src antibody clone 327 was from
Oncogene (Boston, MA). Phosphotyrosine-specific anti-
bodies anti-Src pY418 and anti-Src pY529 (corresponding
to pY415 and pY526 in xSrc) were obtained from
BioSource (Camarillo, CA), and anti-pCdc2 antibody was
from Calbiochem (San Diego, CA). All anti-Src antibodies
could recognize both Xenopus Src1 and Src2 proteins that
have identical amino acid sequences in the regions of
corresponding epitopes. Anti-mouse IgG rabbit polyclonal
antibody was from Cappel (Aurora, OH) and alkaline
phosphatase-conjugated goat polyclonal antibody against
rabbit IgG was from Santa Cruz (Santa Cruz, CA).
[g-32P]ATP (6000 Ci/mmol) was purchased from Perkin-
Elmer (Boston, MA). mMESSAGEmMASHINE RNA
transcription kit and the RNase inhibitor SUPERaseIn were
obtained from Ambion (Austin, TX). RNeasy purification
kit was from Qiagen (Valencia, CA). SuperScript Pream-
plification System for first strand DNA synthesis was from
GibcoBRL (MD, USA). Prostar ULTRA HF system for
real-time polymerase chain reaction (RT-PCR) and pfu
DNA polymerase were from Stratagene (CA, USA). SYBR
green and TaqMan master mix kits for real-time PCR
detection were from Applied Biosystems. Progesterone and
poly (Glu–Tyr) were obtained from Sigma (St. Louis, MO).
PP1, PP2, and PP3 were from Calbiochem. DEAE-cellulose
(DE52) was purchased from Whatman (Kent, UK) and
protein A-Sepharose was from Amersham Pharmacia. Other
chemicals were from Nacalai Tesque (Kyoto, Japan), Wako
(Osaka, Japan), or Sigma.
Preparation of Xenopus oocytes
To obtain oocytes, frogs were anesthetized on ice
followed by rapid decapitation, then ovaries were surgically
removed and placed into OR-2 solution containing 82.5
NaCl, 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mMNa2HPO4, 5 mM HEPES, pH 7.8. Ovaries were manually
dissected into clumps of 50–100 oocytes and extensively
washed with OR-2 solution. Clumps of oocytes were treated
with 0.5 mg/ml collagenase (280 U/mg) in OR-2 at 238C for
3 h by shaking at 60 revs/min. Oocytes were extensively
washed in OR-2 solution and left for stabilization over 4 h.
Undamaged defolliculated oocytes of stage VI were
manually selected. Maturation was induced by addition of
10 AM progesterone and monitored by occurrence of GVBD
judged by appearance of a white spot on the animal
hemisphere of oocytes. Presence of germinal vesicle was
also confirmed by its detection in dissected oocytes after
their fixation in 10% TCA. Quantitative injection of Src
mRNA into oocytes was made under microscopic observa-
tion with a pulse-directed injector system (Drummond,
Nanoject). RNA solutions were loaded into oil-filled glass
microcapillary needles with a tip diameter of 10–30 Am.
About 50 ng of RNA dissolved in RNase-free water was
injected per oocyte in a total volume of 50 nl. Samples of
oocytes were frozen in liquid nitrogen and stored at 808C
until use.
Plasmids and mutagenesis
Xenopus scr2 gene was amplified using mRNA isolated
from Xenopus liver with RNeasy RNA purification kit.
First-strand cDNA was synthesized with SuperScript Pre-
amplification System and polymerase chain reaction (PCR)
was performed with pfu DNA polymerase using the sense
primer 5V-AAAAGATCTAGGGCCCATGGGTGCCAC-
TAAAAGCAAGCC-3V and the anti-sense primer 5V-
AAAGGTACCGGGCCCTAAAGGTTGTCCC -
CAGGCTGGTA-3V. The amplified full-length xSrc DNA
fragment was inserted into the pCR-TOPO vector (pCR/
xSrc) that was used to generate xSrc mutants by PCR-based
methods. Constitutively active xSrc (xSrcKA) had Y526F
mutation at the C-terminal site of regulatory phosphoryla-
tion. It was generated using the sense primer 5V-TTT-
GGAATTCTCCTGACCGAGCTCACCACC-3V and the
anti-sense primer 5V-AAAGGTACCGGGCCCTAAAGG-
TTGTCCCCAGGCTGGAA-3V. The kinase-negative form
(xSrcKN) was mutated at ATP binding site (K294M). It was
produced with the sense primer 5V-CCACTCGAGTGGC-
CATCATGACTCTGAAGC-3Vand the anti-sense primer 5V-
AAAGGTACCGGGCCCTAAAGGTTGTCCC -
CAGGCTGGTA-3V. All xSrc mutants contained R121H
substitution at mAb327 antibody recognition site that was
generated with the primers 5V-CTGGTGGTTGGCA-
CATTCCCTAAGCTCTG-3V and 5V-CAGAGCTTAGG-
GAATGTGCCAACCACCAG-3V. This substitution
rendered xSrc immunoreactive with the mAb327 antibody.
In detail, identification of mAb327 antibody recognition
determinant will be described elsewhere. All xSrc mutants
were subcloned into ApaI site of pBluescript II (SK)
vector (Toyobo) with the upstream T7 promoter to allow in
vitro RNA synthesis.
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In vitro RNA transcription coupled with capping by 7-
methyl-guanosine at the 5Vend was performed from SpeI-
linearized pBluescript plasmid using mMESSAGEmMA-
SHINE T7 high-yield capped RNA transcription kit,
according to the manufacturer’s manual. Purification of the
synthesized message was carried out with RNeasy purifica-
tion kit. Posttranscriptional polyadenylation of synthetic
mRNA at the 3Vend with Escherichia coli poly(A) polymer-
ase was done according to the described protocol (Wor-
mington, 1991). After purification with RNeasy purification
kit, RNA was dissolved in RNase-free water at 1 mg/ml,
which solution was used for microinjections into oocytes.
RNA quality was controlled by denaturing agarose/form-
aldehyde electrophoresis performed essentially as described
earlier (Sambrook and Russell, 2001).
Real-time PCR
Total mRNA was isolated from Xenopus oocytes using
RNeasy RNA purification kit and first-strand cDNA was
generated with Prostar ULTRA HF RT-PCR system using
poly(dT) or random primers. Real-time PCR (RT-PCR) was
carried out with the use of ABI PRISM 7000 thermocycler
(Applied Biosystems). The sense primer 5V-CTGCTTG-
TCTGTCTCTGAC-3V and the anti-sense primer 5V-GTT-
CCAAGTGCCCATCCAA-3Vwere used to detect xSrc DNA
by SYBR Green detection system. An independent set of
primers, the sense primer 5 V-GCAAACACGCA-
GATGGCCTA-3V and the anti-sense primer 5V-CCAAAG-
CAGCCCTGTCCAAG-3V with the TaqMan probe 5V-
CACCGCCTGACCGCTGTTTGTCCC-3V, was employed
with TaqMan detection system. In both approaches, the
GAPDH gene was used as a housekeeping gene.
Partial purification of xSrc from the particulate fraction of
oocytes
The procedure was carried out essentially as described
earlier (Sato et al., 1996). Briefly, oocytes in a packed
volume of 1 ml were mixed with 3 ml of homogenization
buffer containing 20 mM Tris–HCl, pH 7.5, 1 mM EDTA,
1 mM EGTA, 10 mM h-mercaptoethanol, 1 mM sodium
vanadate, 10 Ag/ml leupeptin, 20 AM APMSF, and
disrupted in a Teflon glass homogenizer. The homogenate
was centrifuged at 15,000  g for 15 min and the
supernatant was further clarified by centrifugation at
100,000  g for 1 h. The pellet was washed once again
with the homogenization buffer by centrifugation at
100,000  g for 30 min. Resulting pellet fraction was
solubilized in 1 ml of homogenization buffer containing
1% Triton X-100 (buffer HB+). After centrifugation at
100,000  g for 30 min, the supernatant was applied on a
DEAE-cellulose column (0.5  1 cm) equilibrated with the
same buffer. The column was washed with buffer HB+ andxSrc-containing protein fraction was eluted with 0.5 ml of
100 mM NaCl in the same buffer. Samples were dialyzed
against buffer HB+ and stored at 208C until use.
Protein kinase assay
Tyrosine kinase activity of xSrc-containing detergent
soluble particulate fraction of oocytes was measured with
poly (Glu–Tyr), as a protein substrate, and the activity of
immunoprecipitated xSrc was estimated with a synthetic
cdc2 peptide corresponding to amino acids 7–26 of the
fission yeast cdc2 gene product. The reaction mixture of
protein tyrosine kinase assay (20 Al) contained 50 mM Tris–
HCl, pH 7.5, 5 mM MgCl2, 1 mM dithiothreitol, 1 mg/ml
poly (Glu–Tyr), 2 AM [g-32P]ATP (2 ACi), and 5–10 Al of
DEAE eluates containing normalized amount of protein (5
Ag of total protein corresponding to about 10 oocytes) or 10
Al of immunoprecipitates. Samples were incubated for 10
min at 308C then kinase reaction was terminated by the
addition of concentrated SDS-PAGE sample buffer. Proteins
were separated by SDS-PAGE (Laemmli, 1970) on 10% or
15% gels and radioactive bands of phosphorylated products
were visualized and quantified by BAS2000 image analyzer
(FUJI Film, Japan).
Immunoprecipitation
Frozen oocytes were vortex mixed with 10 volumes of
ice-cold homogenization buffer containing 1% Triton X-100
then sonicated for 2 min on ice with a TOMY UD-201
ultrasonic disrupter (Tomy Seiko, Tokyo). Samples were
centrifuged for 10 min at 15,000 rpm then 200-Al aliquots of
supernatants were incubated with 10 Ag of anti-xSrc
antibody (IgG fraction) raised against a synthetic peptide
corresponding to the residues 410–428 of chicken c-Src for
2 h at 48C. To collect immune complexes, protein A-
Sepharose was added to the samples at a final concentration
of 5% w/v for 1 h. Nonspecifically bound proteins were
washed with the buffer containing 50 mM Tris–HCl, pH
7.5, 150 mM NaCl, 1% Triton X-100, 1% sodium
deoxycholate, 0.1% SDS. Finally, immune complexes were
washed with tyrosine protein kinase reaction mixture
lacking protein/peptide substrates and ATP.
Immunoblotting
Twenty microliters of DEAE eluates was analyzed by
immunoblotting with xSrc-specific antibodies in Figs. 3 and
4. In other experiments (Figs. 5, 6 and 7), 2–5 Al of
clarified oocyte homogenates (1:10 in buffer HB+) was
taken for analysis. Protein samples were separated by SDS-
PAGE on 10% polyacrylamide gels and transferred to
PVDF membranes using a semidry blotting device (Bio-
Rad). Membranes were blocked with T-TBS buffer (20 mM
Tris–HCl, pH, 7.5, 150 mM NaCl, 0.05% Tween 20)
containing 3 mg/ml bovine serum albumin and incubated at
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anti-xSrc, -pY418, -pY529, -pMAPK, -MAPK, and -pCdc2
antibodies or with 100-fold diluted monoclonal antibody
mAb327. After treatment with the monoclonal antibody, the
membranes were incubated with anti-mouse IgG rabbit
polyclonal antibody at a 500-fold dilution for 1 h. All
membranes were treated with a 1000-fold diluted alkaline
phosphatase-conjugated goat polyclonal antibody against
rabbit IgG. Membranes were thoroughly washed with T-
TBS buffer and incubated in developing buffer (100 mM
Tris–HCl, pH 9.5, 5 mM MgCl2, 100 mM NaCl, 50 Ag/ml
5-bromo-4-chloro-3-indolyl phosphate p-toluidine salt, and
150 Ag/ml nitro blue tetrazolium) to visualize the immune
complexes.
Other methods
Protein content in the samples was determined spectro-
photometrically using a protein assay kit (Bio-Rad). Mass
spectrometric identification of xSrc as a mixture of Src1 and
Src2 proteins will be described elsewhere (Iwasaki et al.,
unpublished data).Fig. 1. xSrc activity in a plasma membrane-containing fraction of maturing
Xenopus oocytes. A particulate fraction of maturing oocytes was obtained
by ultracentrifugation of detergent-free homogenates. Proteins were
solubilized in Triton X-100-containing buffer and subjected to DEAE-
cellulose chromatography, as described in the Experimental procedures.
Protein kinase activity eluted from the DEAE column at 100 mM NaCl was
measured with the use of poly (Glu–Tyr), as a substrate of tyrosine kinases,
in the presence of the Src family kinase specific inhibitor PP2 or its inactive
analog PP3, both at 10 AM. Each sample of kinase assay contained 5 Ag of
solubilized particulate fraction protein corresponding to about 10 oocytes.
After SDS-PAGE, radioactive bands of phosphorylated substrate were
visualized and quantified by BAS2500 image analyzer (FUJI Film) (A and
B). Panel C shows the time course of MAPK activation and GVBD after the
addition of 10 AM progesterone to oocytes. Data of a representative
experiment are shown in panels A and C. In panel B, data are means F SD
of three independent experiments performed in duplicates with different
batches of oocytes. Asterisk indicates a significant difference from the
control (P b 0.05).Results
Overall profile of Src kinase activity during Xenopus oocyte
maturation
xSrc activity is localized mainly in a particulate plasma
membrane-containing fraction of Xenopus oocytes, as
reported previously (Sato et al., 1996). Proteins of this
fraction were solubilized in a detergent-containing buffer
and subjected to DEAE-cellulose column chromatography,
according to the Experimental procedures. After normaliz-
ing total protein content, protein kinase assay was
performed with poly Glu–Tyr as a substrate in the presence
of the Src-specific inhibitor PP2 or its inactive analog PP3
(Hanke et al., 1996). Both Src-specific (PP2-sensitive) and -
nonspecific (PP2-insensitive) tyrosine kinase activity could
be reliably detected by this method in the samples prepared
from as few as 10 oocytes, with Src-specific activity
normally exceeding the nonspecific one (Fig. 1A). Using
this approach, we measured endogenous Src kinase activity
in oocytes during progesterone-induced maturation and
found that Src-specific tyrosine phosphorylation in the
plasma membrane-containing fraction varied in the process
of maturation, whereas Src-nonspecific tyrosine kinase
activity remained virtually unchanged (Fig. 1B). Src-
specific tyrosine kinase activity transiently increased about
2-fold within 3 min after progesterone administration, then
fell down and remained at the level of untreated control until
the time of MAPK activation and GVBD. At that time, Src-
specific kinase activity increased again by about 2-fold and
remained this elevated till the completion of maturation
(Figs. 1B and C). A similar profile of xSrc kinase activitywas obtained in the kinase assay of the enzyme immuno-
precipitated from detergent-soluble plasma membrane-con-
taining fractions (see next section).
Immunoprecipitation kinase assay of xSrc
Evaluation of Src kinase activity by the above technique
relied greatly on the specificity of the PP2 inhibitor.
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SFKs, it was also reported to inhibit the activity of some
other tyrosine kinases (Bain et al., 2003). Moreover, PP2
does not discriminate between the different SFK members.
Therefore, to confirm changes in Src activity during
maturation, we performed protein kinase assay of xSrc
kinase immunoprecipitated from detergent-soluble plasma
membrane-containing fractions of Xenopus oocytes using
the synthetic cdc2 peptide as an alternative substrate. High
abundance of the enzyme in the reaction mixture of protein
kinase reaction also allowed the detection of xSrc auto-
phosphorylation in the immunoprecipitation assay. It should
be noted, however, that the anti-peptide antibody against the
activation segment of Src, which was used to immunopre-
cipitate xSrc kinase in these experiments, could also react
with other SFK members, such as Yes, Fyn, and so forth.
Nevertheless, mass spectrometry of the major immunopre-
cipitation product at 60 kDa could reveal only the presence
of xSrc protein, but not other SFKs (Iwasaki et al.,
unpublished data), evidently due to the fact that xSrc
represents the major SFK expressed at the protein level in
Xenopus oocytes (Sato et al., 1996). Protein kinase activity
of immunoprecipitates was greatly inhibited by the specific
inhibitor of Src activity PP1 (Hanke et al., 1996), thus
confirming that Src kinase constituted a major protein
tyrosine kinase in the assay (Fig. 2A). Both autophosphor-
ylation and phosphorylation of the Src-specific peptideFig. 2. Immunoprecipitation kinase assay of xSrc in maturing oocytes.
Kinetics of early and late meiotic Src activation are shown in panels A and
B, correspondingly. xSrc kinase was immunoprecipitated from a detergent-
soluble particulate fraction of control and progesterone-treated oocytes with
the antibody raised against Src activation segment. To determine Src-
specific activity, Src autophosphorylation and phosphorylation of the Src-
specific substrate cdc2 peptide were analyzed. Nonspecific protein kinase
activity (panel A, right lane) was measured in the control immunopreci-
pitate from untreated oocytes in the presence of the Src family kinase-
specific inhibitor PP1 (10 AM). The results are representative of three
experiments with different batches of oocytes. Bars in the lower panels are
means F SD of three independent experiments performed in duplicates.
Asterisk indicates a significant difference from the control (P b 0.05).substrate in the immunoprecipitates increased about 2-fold
within 3–5 min of progesterone administration and gradu-
ally declined afterwards (Fig. 2A). Later in maturation, Src
kinase activity increased again by the time of GVBD and it
remained elevated till the completion of maturation, as
judged by both autophosphorylation and cdc2 peptide
phosphorylation (Fig. 2B). These results are in good
agreement with the data of Fig. 1 and confirm the two-
phase character of xSrc activation during Xenopus oocyte
maturation.
Specific activity and tyrosine phosphorylation of xSrc
during maturation
Although the total protein content in the samples of
kinase assay was normalized (5 Ag/assay), it was unclear
whether the amount of Src protein in the assay was constant.
Therefore, levels of Src protein in the samples of Fig. 1 were
analyzed by Western blotting with an antibody raised
against a synthetic peptide corresponding to the Src
activation segment. Using this antibody, xSrc partially
purified by DEAE-chromatography appeared on the blots
as one major band usually accompanied by a minor doublet
of a higher molecular weight. All these bands were
considered as xSrc specific in the estimation of Src content
in maturing oocytes. On the blots, total content of xSrc
protein did not change significantly during the first 2 h of
maturation, then increased about 2-fold after 4 h of
progesterone administration at the time of GVBD and
MAPK activation and remained this increased till the
completion of maturation (Fig. 3A). On the other hand,
xSrc-specific activity, calculated as a ratio of PP2-dependent
tyrosine phosphorylation of poly (Glu–Tyr) in a radioactive
kinase assay (data of Fig. 1) to xSrc protein content, was
significantly increased at the time of early xSrc stimulation
within 3 min after progesterone application but remained
low at the time of GVBD (Fig. 3A). It was therefore
concluded that activation of plasma membrane-associated
xSrc occurs early upon progesterone treatment, whereas
elevation of Src activity at GVBD is due to the increase of
xSrc protein content.
To further investigate xSrc regulation during maturation,
a phosphorylation site-specific antibody against C-terminal
phosphoregulatory tyrosine has been employed. Immuno-
blotting with this antibody revealed that the increase in the
total amount of xSrc at GVBD was accompanied by parallel
changes in pY526 content. However, the extent of C-
terminal tyrosine phosphorylation, as calculated by normal-
izing the content of phosphotyrosine to the total xSrc
protein content, did not alter significantly during maturation
(Fig. 3B).
xSrc content in maturing oocytes
Data presented above strongly suggested that a change
in xSrc protein content, but not posttranslational modifi-
Fig. 4. Content of xSrc mRNA and protein in maturing oocytes. In panel A,
relative content of xSrc in DEAE chromatography-purified particulate
fraction obtained from several different batches of maturing oocytes was
determined by immunoblotting with the anti-peptide antibody against the
activation segment of Src. Data represent means F SD of five independent
experiments. Asterisk indicates a significant difference from control (P b
0.05). Panel B shows the relative content of xSrc mRNA in maturing
oocytes measured by RT-PCR using TaqMan and SYBR green detection
techniques with two different sets of primers. TaqMan data are meansF SD
of four measurements in two independent runs. Bars in SYBR green
represent the range of duplicate samples in the same run. Data in the
highlighted areas depict oocyte populations with more than 50% GVBD.
Fig. 3. Specific activity and site-specific tyrosine phosphorylation of xSrc
during maturation. DEAE chromatography-purified particulate fraction of
maturing oocytes was immunoblotted with anti-xSrc or anti-pY526
antibodies (panels A and B, correspondingly), as described in the
Experimental procedures. Specific bands are denoted with arrows. Band
intensity was estimated using Image Gauge V3.45 software (FUJI, Japan).
Src-specific activity in panel A was calculated as a ratio of PP1-dependent
tyrosine phosphorylation presented in Fig. 1 to xSrc protein content
determined by immunoblotting. Relative band intensity in panel B
represents a ratio of phosphotyrosine content in the C-terminal phosphor-
ylation site to xSrc protein content. The results are representative of three
experiments with different batches of oocytes.
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Src activity in meiotic metaphase. To address this point in
more detail, the amount of xSrc in DEAE chromatography-
purified samples of detergent-soluble particulate fraction
obtained from several different batches of maturing
oocytes was analyzed by immunoblotting with a Src-
specific antibody. Although the initial content of xSrc in
oocytes varied from batch to batch, the tendency to its
increase at the time of GVBD persisted in all batches
resulting in a clear statistical difference from the untreated
control (Fig. 4A).
Next we estimated the content of xSrc mRNA in
oocytes during maturation using the RT-PCR technique.
Considering that a 2-fold difference in mRNA amount is
sometimes difficult to register by this approach due to
variation in parallel measurements, we synthesized two
different sets of specific primers for two different parts of
Src molecule (see Experimental procedures). In addition,
two different detection techniques, such as TaqMan and
SYBR Green, were used in RT-PCR experiments. These
measurements could not reveal any statistically significant
differences in xSrc mRNA content during maturation
(Fig. 4B), implying that the increase in xSrc proteincontent in meiotic M phase is regulated at the posttran-
scriptional level.
Expression of Src mutants in Xenopus oocytes
Src activation at mitosis was suggested to result from
decreased phosphorylation on tyrosine 527 (Bagrodia et al.,
1991). In contrast, our data presented in Fig. 3 showed that
the increase in xSrc activity at meiotic M phase was not
accompanied by changes in the extent of C-terminal
tyrosine phosphorylation and Src-specific activity. To
confirm this finding, the extent of C-terminal tyrosine
phosphorylation was compared in resting and maturing
oocytes overexpressing kinase-negative and wild-type xSrc
proteins. Both proteins were expressed as single-band
products that were heavily phosphorylated on C-terminal
phosphotyrosine. Their expression levels exceeded those of
the endogenous xSrc more than 10-fold, as judged by the
relative band intensities of anti-pY526 immunoblot (Fig.
5A). Similar to endogenous xSrc, the content of pY526 in
Fig. 6. Expression of constitutively active xSrc in individual oocytes.
Clarified extracts (0.2 oocyte/lane) were obtained from control oocytes
(oo), matured oocytes (egg), and four individual oocytes expressing
constitutively active xSrc (numbers 1–4), then subjected to immunoblotting
with indicated antibodies. Eggs were produced by in vitro maturation of
control oocytes in the presence of 10 AM progesterone for 8 h.
Constitutively active xSrc was expressed in resting Xenopus oocytes as
described in Fig. 5. GVBD was monitored by the appearance of a white
spot on the animal hemisphere of oocytes and confirmed by microscopic
detection of germinal vesicle in dissected oocytes after their fixation with
TCA in a parallel experiment.
Fig. 5. Expression of kinase-negative and wild-type xSrc in resting and
maturing oocytes. Xenopus oocytes were microinjected with kinase-
negative (xSrcKN) or wild-type (xSrcWT) mRNA (40 ng/cell) and then
incubated for 8 h at RT in the absence or presence of 10 AM progesterone.
In panel A, xSrc expression level and extent of C-terminal tyrosine
phosphorylation were estimated by immunoblotting clarified oocyte
extracts (0.5 oocyte/lane) with mAb327 and anti-pY526 antibodies,
respectively. Completion of maturation was monitored by immunoblotting
the extracts with anti-pMAPK and anti-pCdc2 antibodies. Panel B shows a
ratio of C-terminal phosphotyrosine content to xSrc protein content.
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progesterone-matured and immature oocytes (Fig. 5B).
To test the ability of Src kinase to trigger meiotic
progression, we also expressed a constitutively active form
of xSrc protein with C-terminal tyrosine mutated to
phenylalanine (xSrcKA) in oocytes. This enzyme displayed
high autophosphorylation activity in the absence of C-
terminal tyrosine phosphorylation, as judged by immuno-
blotting with the phosphorylation site-specific antibodies
anti-pY415 and anti-pY526 (Fig. 6). Side-by-side expres-
sion of Src mutants revealed a slight mobility shift of
xSrcKA protein band, evidently, due to the lack of C-
terminal phosphorylation (data not shown). The single-band
expression pattern of xSrc proteins alongside with the band
mobility shift of constitutively active form implies that xSrc
in oocytes is completely phosphorylated on C-terminal
tyrosine. Analysis of xSrcKA expression in individual
oocytes demonstrated that this mutant induced low-level
MAPK activation in the absence of Cdc2 kinase dephos-
phorylation and cell cycle transition (Fig. 6). The magnitude
of MAPK activation in xSrcKA-expressing oocytes was
much lower than in progesterone-matured oocytes; MAPK
band mobility shift could not be detected indicating that a
major part of MAPK still remained unphosphorylated (i.e.,
inactive) in these cells. Although xSrcKA expression in
oocytes failed to induce meiotic progression in the absence
of progesterone treatment (Figs. 7C and D), it noticeably
accelerated MAPK activation, Cdc2 kinase dephosphoryla-
tion, and GVBD in progesterone-treated oocytes (Figs. 7A,
B, and D). Complete manifestation of these maturation
markers in xSrcKA-expressing oocytes could be registered
within 4 h of progesterone treatment. Importantly, not only
the complete MAPK activation but also its onset could be
detected much earlier in Src-expressing oocytes (bothprogesterone treated and untreated) than in the control
oocytes (see Discussion).Discussion
Although changes of Src activity in the mitotic cell cycle
have been well documented and the regulatory mechanisms
of Src activation in mitosis have been thoroughly inves-
tigated (Bagrodia et al., 1991; Chackalaparampil and
Shalloway, 1988; Kaech et al., 1993), there were no detailed
reports presented concerning Src regulation in the meiotic
cell cycle. The fact that expression of constitutively active
Src kinase in Xenopus oocytes can accelerate oocyte
maturation (Spivack et al., 1984) suggested Src involvement
in meiotic progression.
In the present study, we investigated Src regulation
during progesterone-induced maturation of Xenopus
oocytes. In oocytes, Src is maintained in a low-activity
state (Sato et al., 1996) and it is first transiently activated in
a detergent-soluble plasma membrane-containing fraction of
oocytes within 3 min after induction of maturation by
progesterone (Figs. 1 and 2). This increase in Src activity
represents one of the earliest transcription-independent
responses of oocytes to progesterone.
xSrc is suggested to play an important role in the
transduction of fertilization signal that has been recently
established to require sequential activation of Src family
kinases, phospholipase C (PLCg), and IP3 receptor of the
Fig. 7. Accelerated maturation of Xenopus oocytes expressing constitutively active xSrc. xSrcKA was expressed in Xenopus oocytes as described in Fig. 5.
Clarified extracts were obtained from control maturing noninjected oocytes (A) and xSrcKA RNA-microinjected oocytes incubated in the presence (B) or
absence (C) of 10 AM progesterone for the indicated time. To monitor expression of xSrcKA and progression of maturation, the extracts (0.2 oocyte/lane) were
immunoblotted with anti-pY415 xSrc, anti-pMAPK, and anti-pCdc2 antibodies. Panel D shows the time course of GVBD in progesterone-treated control
oocytes (5) and xSrcKA RNA-microinjected oocytes in the presence (D) or absence (o) of progesterone.
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2000a). Consistently, the Src kinase was shown to induce
calcium release in Xenopus egg CSF-arrested extracts
through PLCg and IP3-dependent mechanisms (Tokmakov
et al., 2002b). Interestingly, progesterone too was reported
to induce early stimulation of PLC and accumulation of IP3
in Xenopus oocytes (Morrison et al., 2000; Stith et al.,
1992). These events may be relevant to progesterone action,
since reducing PIP2 hydrolysis, IP3-receptor availability, or
calcium gradients was shown to inhibit progesterone-
induced maturation of Xenopus oocytes (Han and Lee,
1995). Furthermore, using a plasma membrane cortex
preparation, progesterone has been demonstrated to act
through a plasma membrane-associated tyrosine kinase to
activate PLC in Xenopus oocytes (Morrison et al., 2000).
Stimulation of tyrosine kinase activity could be detected
within 10 min of progesterone administration. Although the
identity of progesterone-stimulated tyrosine kinase is not
established, tyrosine kinase activity seems to be important
for the induction of maturation, microinjections of a tyrosine
phosphatase or antibodies against phosphotyrosine inhibit
this process (Hainaut et al., 1991; Tonks et al., 1990).
In the present paper, we identify membrane-associated
Src kinase as a tyrosine kinase activated early upon
progesterone treatment. Recently, progestins have been
shown to promote rapid association of Src with the
progesterone receptor resulting in Src activation in mamma-
lian cells (Boonyaratanakornkit et al., 2001; Migliaccio et
al., 1998). Also, Src downstream effector MAPK was
reported to be activated in progesterone-treated mammalian
cells (Migliaccio et al., 1998), suggesting that the classical
progesterone receptor may transmit a hormone signal
through the Src/Ras/MAPK pathway. In Xenopus oocytes,
a transient low-level activation of MAPK has been
registered shortly after progesterone application (Fisher et
al., 2000), implying that the same signaling pathway also
operates in oocytes. Early activation of MAPK in oocytes
was suggested to occur through a Ras/Raf-dependent
mechanism; however, at present, its role in the initiation
of meiotic progression is not established.In oocytes, MAPK is embedded in a loop of protein
synthesis-dependent positive feedback that promotes MPF
activation and meiotic progression (Ferrell, 1998; Tokma-
kov et al., 2002a; Tunquist and Maller, 2003). Micro-
injections of MAPK protein can induce complete MPF
activation and meiotic progression in Xenopus oocytes in
the absence of progesterone, whereas preventing MAPK
activation inhibits or delays MPF activation and GVBD
(Gotoh et al., 1995; Tokmakov et al., 1998). Although
MAPK normally plays a major role in the progesterone-
induced activation of MPF, recent results with the MEK
inhibitor U0126 indicate that it is possible to induce MPF
and GVBD in the absence of detectable MAPK activation
(Gross et al., 2000). Also, MAPK inhibition by Pyst1
phosphatase delays but does not prevent initiation of
maturation (Fisher et al., 1999). More recently, it has been
found that blocking Mos synthesis by morpholino antisense
oligonucleotides does not prevent progesterone-induced
Cdc2 activation and GVBD; however, it substantially delays
both events (Dupre et al., 2002). These findings demonstrate
that although Mos synthesis and MAPK activation contrib-
ute considerably to maturation, they are dispensable for this
process.
It has been reported earlier that the expression of
deregulated highly active mutant of Src accelerated proges-
terone-induced maturation of Xenopus oocytes, increased
content of tyrosine-phosphorylated proteins, and stimulated
the activity of MAPK downstream S6 kinase RSK (Spivack
et al., 1984; Unger and Steele, 1992). Consistently, we
detected MAPK activation in Xenopus oocytes expressing
constitutively active but not wild-type or kinase-negative
xSrc (Figs. 6 and 7). However, the extent of MAPK
activation was low, and GVBD, a morphological marker of
meiosis I, did not occur in these oocytes, indicating that Src
alone is not sufficient to promote complete maturation and
some other pathways should cooperate in this process.
Interestingly, on rare occasions, we detected GVBD in some
batches of ultrasensitive oocytes expressing constitutively
active xSrc in the absence of progesterone; however, these
oocytes had a high rate of spontaneous maturation and
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GVBD within 2 h (data not shown). Presumably, these
batches of oocytes were obtained from hormonally com-
promised animals. Although MAPK activity in xSrcKA-
expressing oocytes was much lower than that in matured
eggs, it exceeded many fold the level of MAPK activity in
resting oocytes (Figs. 6 and 7). Importantly, MAPK
activation in oocytes expressing Src kinase in the absence
of progesterone could be detected much earlier than MAPK
activation in the course of normal maturation. Also, Src
expression in progesterone-treated oocytes resulted in the
accelerated onset of MAPK activation (Fig. 7). By promot-
ing MAPK activation, Src kinase in maturing oocytes is
embedded in the same loop of positive feedback that
induces MPF activation and meiotic progression. Accord-
ingly, accelerated dephosphorylation (activation) of Cdc2
kinase also takes place in maturing Src-expressing oocytes
(Fig. 7). We suggest therefore that Src kinase acts through
the MAPK pathway to accelerate oocyte maturation. More
direct evidence for this comes from the fact that the MEK
inhibitor U0126 abolishes the stimulatory effect of xSrcKA
on maturation—it inhibits maturation of control and Src-
expressing oocytes to the same extent (manuscript in
preparation).
After the initial transient elevation at the beginning of
progesterone treatment, Src activity returns to the control
level and increases again at the time of GVBD in meiotic M
phase (Figs. 1 and 2). Although this is reminiscent of
mitotic Src activation, mechanisms underlying the increase
of Src activity seem to be different in mitosis and meiosis.
The fact that Src-specific activity does not change at GVBD
indicates that no bona fide enzyme activation occurs in
meiotic metaphase. Rather, the elevation of Src activity in
meiosis is related to the increase of total Src protein content
(Figs. 3 and 4). As a result, in matured oocytes arrested at
the second meiotic metaphase (they can also be referred as
unfertilized eggs), Src kinase is maintained in the same
low-activity state as in immature G2 phase-arrested
oocytes. This finding is in good agreement with previous
observations indicating that Src kinase is inactive in
Xenopus eggs and is transiently and robustly activated
upon fertilization (Sato et al., 1996). On the other hand,
mitotic activation of Src in mammalian cells was shown to
result from decreased phosphorylation on C-terminal
tyrosine (Bagrodia et al., 1991). However, in maturing
Xenopus oocytes, we failed to detect any decrease in pY526
relative content in meiotic M phase (Fig. 3B). Also, the
content of pY526 in overexpressed Src proteins was found
to be the same in progesterone-matured and immature
oocytes (Fig. 5B). Altogether, these results indicate that in
contrast to mitosis, posttranslational phosphorylation on C-
terminal tyrosine does not play an essential role in the
meiotic regulation of Src activity.
At present, biological implications of Src activity
changes in meiosis are not clear. Nongenomic Src
activation immediately after induction of maturation maybe related to triggering some early signaling pathways of
maturation, whereas stock-piling inactive Src protein later
in meiotic metaphase may serve a purpose of increasing the
robustness of fertilization signal mediated by Src activa-
tion. It may also be related to Src-mediated activation of
some other signaling proteins that are involved in the
regulation of meiotic progression. In this connection, Xp95
putative signal transduction protein recently cloned in
Xenopus oocytes should be mentioned (Che et al., 1999).
This protein was found to be phosphorylated from the first
through the second meiotic divisions during progesterone-
induced oocyte maturation. Remarkably, it can be phos-
phorylated by SFKs in vitro and expression of deregulated
Src in Xenopus oocytes increases the abundance of
tyrosine-phosphorylated Xp95, suggesting that Src can
also regulate this protein during physiological oocyte
maturation.References
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